JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M704686200 on October 28, 2007

J. Biol. Chem., Vol. 283, Issue 1, 66-75, January 4, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
283/1/66    most recent
M704686200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gallegos, J. R.
Right arrow Articles by Lu, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gallegos, J. R.
Right arrow Articles by Lu, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

SCFβTrCP1 Activates and Ubiquitylates TAp63{gamma}*Formula

Jayme R. Gallegos{ddagger}1, Joel Litersky{ddagger}, Hunjoo Lee{ddagger}, Yi Sun§, Keiichi Nakayama||, Keiko Nakayama**, and Hua Lu{ddagger}{ddagger}{ddagger}2

From the {ddagger}Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, Oregon 97239, the {ddagger}{ddagger}Department of Biochemistry and Molecular Biology, University of Indiana, Indianapolis, Indiana 46202, the §Department of Radiation Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan 48109, the Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, Fukuoka 812-8582, Japan, ||CREST, Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan, and the **Department of Developmental Biology, Center for Translational and Advanced Animal Research, Graduate School of Medicine, Tohoku University, 2-1 Seiryo, Aoba-ku, Sendai 980-8575, Japan

p63 is a member of the p53 tumor suppressor family that is critical for epithelial differentiation and also has an important role in cancer progression. Currently, the molecular mechanisms governing regulation of p63 function remain largely unclear. This study identifies a unique E3 ubiquitin ligase for p63, SCFβTrCP1. SCFβTrCP1 is able to bind p63{gamma} isoforms, with a higher affinity for the TAp63{gamma} isoform. Strikingly, co-expression of TAp63{gamma} and βTrCP1 leads to the stabilization of TAp63{gamma}. This stabilization of TAp63{gamma} leads to up-regulation of p21 at the mRNA and protein level by increased binding of TAp63{gamma} at the p21 promoter. The up-regulation of p21 causes a subsequent increase in G1 phase cell cycle arrest. Last, SCFβTrCP1 is able to ubiquitylate TAp63{gamma}, and this ubiquitylation, as well as the increased activity of TAp63{gamma}, is ablated with the expression of a ubiquitin-deficient mutant of βTrCP1 ({Delta}FβTrCP1). Therefore, our study reveals that SCFβTrCP1 is an E3 ligase that activates p63 through ubiquitylation.


Received for publication, June 7, 2007 , and in revised form, October 26, 2007.

* This work is supported in part by NCI, National Institutes of Health Grants CA 93614, CA 095441, and CA 079721 (to H. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2.

1 Recipient of funding from an Oregon Health and Science University Department of Dermatology predoctoral fellowship (National Institutes of Health) and an Oregon Health and Science University Ophthalmology and Immunology predoctoral research fellowship (National Institutes of Health).

2 To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, University of Indiana, 635 Barnhill Dr., MS 4053, Indianapolis, IN 46202. Tel.: 317-278-0920; E-mail: hualu{at}iupui.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. MacPartlin, S. X. Zeng, and H. Lu
Phosphorylation and Stabilization of TAp63{gamma} by I{kappa}B Kinase-{beta}
J. Biol. Chem., June 6, 2008; 283(23): 15754 - 15761.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.